Published: September 23, 2006Received: March 09, 2006Available on J-STAGE: September 23, 2006Accepted: April 30, 2006
Advance online publication: September 07, 2006
Revised: -
L-Pipecolic acid is a chiral pharmaceutical intermediate. An enzymatic system for the synthesis of L-pipecolic acid from L-lysine by commercial L-lysine α-oxidase from Trichoderma viride and an extract of recombinant Escherichia coli cells coexpressing Δ1-piperideine-2-carboxylate reductase from Pseudomonas putida and glucose dehydrogenase from Bacillus subtilis is described. A laboratory-scale process provided 27 g/l of L-pipecolic acid in 99.7% e.e.
References (25)
Related articles (0)
Figures (0)
Content from these authors
Supplementary material (0)
Result List ()
Cited by
This article cannot obtain the latest cited-by information.